Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    NCT01369212
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir;   Drug: Peginterferon-alfa 2a and tenofovir
2 Active, not recruiting HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
Condition: Hepatitis B

Indicates status has not been verified in more than two years